首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Infectious Diseases And Therapy

Infectious Diseases And Therapy杂志,由Springer Healthcare出版,于2012年创刊,6 issues per year,出版语言English,ISSN:2193-8229,E-ISSN:2193-6382。

投稿咨询
Infectious Diseases And Therapy
Infectious Diseases And Therapy
Infectious Diseases And Therapy
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.6
CiteScore
9.3
期刊收录
SCI、SCIE

Infectious Diseases And Therapy(中文译名:《传染病与治疗》),ISSN:2193-8229,EISSN:2193-6382,是Springer Healthcare出版的国际性学术期刊,创刊于2012年,以6 issues per year形式稳定发行,2026年总发文量约173篇。该刊采用OA开放访问,学科归属为Medicine - Microbiology (medical)。该刊是医学、传染病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.6,2025年期刊CiteScore为9.3,2025年期刊自引率约5.4%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Infectious Diseases And Therapy长期聚焦医学、传染病学及相关产业的技术应用前沿,平均审稿周期6 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、传染病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Italy、GERMANY (FED REP GER)、Belgium、Canada、CHINA MAINLAND等为核心发文国家与地区;WAYNE STATE UNIVERSITYPFIZER、GLAXOSMITHKLINE、DETROIT MEDICAL CENTER、NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS、HENRY FORD HOSPITAL、UNIVERSITY OF CALIFORNIA SYSTEM等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
INFECTIOUS DISEASES 传染病学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
INFECTIOUS DISEASES 传染病学
2区

期刊分区表(2022年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
INFECTIOUS DISEASES 传染病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q1 16 / 141

89

学科:INFECTIOUS DISEASES SCIE Q1 15 / 141

89.72

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INFECTIOUS DISEASES SCIE Q1 20 / 132

85.2

学科:INFECTIOUS DISEASES SCIE Q1 32 / 132

76.14


中国学者近期发文

1
Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Revie

Author:Ge, Rui; Nian, Xinwen; Liu, Benjuan; Yang, Yunyun; Wang, Zhuo

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. 15, Issue 5, pp. 1203-1248. DOI: 10.1007/s40121-026-01341-4

2
Post-marketing Safety Surveillance of 23-Valent Pneumococcal Polysaccharide Vaccine Administered Alone and Concomitantly with Influenza Vaccine in Individuals Aged 2 Years and Older in Chin

Author:Shi, Yun-feng; Ju, Lin-hang; Wang, Kang-ning; Pan, Yu; Zou, Yu-ying; Lu, Xi; Tuo, Ling; Zou, Wen-tao; Wei, Ming-wei; Zhao, Yan-wei; Pan, Hong-xing

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01309-4

3
Reimagining Phage Therapy for MDR Pathogens: From Biobanks to Health System Integration-A Revie

Author:Ayele, Abay A.; Liu, Wenfeng; Xiao, Minfeng; Kalayu, Alem A.; Abegaz, Woldaregay E.; Negash, Abel A

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01320-9

4
The Impact and Effectiveness of a Two-Dose Varicella Immunization Program Among School Children: Evidence from Quasi-experimental Analyse

Author:Gu, Huiqiao; Xie, Xu; Lv, Qiuying; Cui, Yuantian; Lu, Ziyan; Akhmetova, Zaure; Shulgau, Zarina; Huang, Fang; Jiang, Yawen

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01331-6

5
Rising Burden of Herpes Zoster among General Adults and Increased-Risk Groups in Eastern China, 2015-2021: A Population-Based Cohort Stud

Author:Li, Zhenwei; Gu, Shenjia; Li, Jiajun; Zhang, Guomin; Wu, Zheng; Lin, Hongbo; Chen, Kan; Xu, Zhexin; Fu, Chuanxi

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01308-5

6
Early Antibiotic Therapy in Sepsis Without Shock: A Multimethod Study of Heterogeneous Treatment Effects in ICU Patient

Author:Zhang, Peng; Zuo, Tongkun; Zhu, Xingxing; Wei, Jilou; Wang, Min; Zhang, Xiangcheng; Huang, Ying

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-026-01316-5

7
How Status Quo Bias Shapes Willingness, Uptake, and Adherence to PrEP Among Chinese MSM: A Behavioral Economics Perspectiv

Author:Zhao, Min; Zhao, Xiang; Zhang, Ye; Yin, Zhuoheng; Ji, Fanpu; Ong, Jason J.; Tang, Weiming; Zhang, Lei

Journal: INFECTIOUS DISEASES AND THERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01296-y

8
Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulatio

Author:Hu, Na; Xiao, Fengjiao; Chen, Yechao; Gu, Qiaoling; Liang, Pei; Xu, Yin; Liu, Jinchun; Liu, Yunxing; Li, Yi-chen; Xu, Yinqiu; Liu, Mengyin; Chen, Dayu; Zhang, Haixia

Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01164-9

9
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study

Author:Huang, Chung-Feng; Heo, Jeong; Chien, Rong-Nan; Baek, Yang-Hyun; Kao, Jia-Horng; Kim, Ju-Hyun; Chang, Ting-Tsung; Byun, Kwan-Soo; Chen, Jyh-Jou; Jeong, Sook-Hyang; Hu, Tsung-Hui; Kim, Young-Seok; Peng, Cheng-Yuan; Tak, Won-Young; Wang, Horng-Yuan; Yoon, Seung-Kew; Sheen, I. -Shyan; Hsu, Yu-Chun; Yim, Hyung-Joon; Tsai, Pei-Chien; Yeh, Ming-Lun; Ahn, Sang-Hoon; Dai, Chia-Yen; Paik, Seung-Woon; Huang, Jee-Fu; Kim, Yoon-Jun; Chuang, Wan-Long; Lim, Young-Suk; Yu, Ming-Lung

Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s40121-025-01145-y

10
Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014-202

Author:Wang, Hanli; Li, Shirong; Ji, Haoyu; Hu, Yixin; Zhou, Susheng; Chen, Xingwu; Lu, Zhiwei; You, Qinghai; Cheng, Yusheng; Zha, Lei

Journal: INFECTIOUS DISEASES AND THERAPY. 2025; Vol. 14, Issue 1, pp. 261-274. DOI: 10.1007/s40121-024-01099-7


在线咨询

Infectious Diseases And Therapy

国际简称:INFECT DIS THER参考译名:传染病与治疗

年发文量:173 CiteScore:9.3 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:81.50%

杂志社联系方式:236 GRAYS INN RD, 6TH FLOOR, LONDON, ENGLAND, WC1X 8HL

Infectious Diseases And Therapy